Thomas Krogh
Geschäftsführer bei VERITAS FARMS, INC.
Aktive Positionen von Thomas Krogh
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VERITAS FARMS, INC. | Geschäftsführer | 25.08.2023 | - |
| Corporate Officer/Principal | 01.01.2020 | 25.08.2023 |
Karriereverlauf von Thomas Krogh
Ehemalige bekannte Positionen von Thomas Krogh
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
CBR International Corp.
 CBR International Corp. Miscellaneous Commercial ServicesCommercial Services Part of Novotech Holdings Pty Ltd., Novotech Drug Development Consulting (formerly CBR International Corp.) is a full-service product development, clinical oversight, and regulatory operations group. The company is based in Boulder, CO. CBR International was acquired by Novotech Holdings Pty Ltd. on January 09, 2023. Novotech Drug Development Consulting provides comprehensive "lab to launch" program development services and is currently assisting companies with COVID-19 development programs and FDA's Coronavirus Treatment Acceleration Program (CTAP). The company was founded in 1999 by Jeanne M. Novak, who has been the CEO since 1999. | Corporate Officer/Principal | - | - |
Ausbildung von Thomas Krogh
| University of Denver | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Process Industries | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VERITAS FARMS, INC. | Process Industries |
| Private Unternehmen | 1 |
|---|---|
CBR International Corp.
CBR International Corp. Miscellaneous Commercial ServicesCommercial Services Part of Novotech Holdings Pty Ltd., Novotech Drug Development Consulting (formerly CBR International Corp.) is a full-service product development, clinical oversight, and regulatory operations group. The company is based in Boulder, CO. CBR International was acquired by Novotech Holdings Pty Ltd. on January 09, 2023. Novotech Drug Development Consulting provides comprehensive "lab to launch" program development services and is currently assisting companies with COVID-19 development programs and FDA's Coronavirus Treatment Acceleration Program (CTAP). The company was founded in 1999 by Jeanne M. Novak, who has been the CEO since 1999. | Commercial Services |
- Börse
- Insiders
- Thomas Krogh
- Erfahrung
